Cisplatin, gemcitabine, vinorelbine (PGV) vs cisplatin and gemcitabine (PG) vs cisplatin, gemcitabine, paclitaxel (PGT) in advanced NSCLC:: Final analysis a phase III trial

被引:0
|
作者
Comella, G [1 ]
Frasci, G [1 ]
Panza, N [1 ]
Nicolella, G [1 ]
Manzione, I [1 ]
De Cataldis, G [1 ]
Cioffi, R [1 ]
Micillo, E [1 ]
Lorusso, V [1 ]
Bilancia, D [1 ]
Maiorino, L [1 ]
Piantedosi, FV [1 ]
Mangiameli, A [1 ]
Gravina, A [1 ]
Lamberti, A [1 ]
De Lena, M [1 ]
Comella, P [1 ]
机构
[1] Tumor Inst Naples, So Italy Cooperat Oncol Grp, Naples, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A10
引用
收藏
页码:3 / 3
页数:1
相关论文
共 50 条
  • [41] A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer
    Hwang, In Gyu
    Jang, Joung-Soon
    Oh, Sung Yong
    Lee, Suee
    Kwon, Hyuk Chan
    Lee, Gyeong Won
    Go, Seil
    Kang, Myoung Hee
    Cha, Young Joo
    Kang, Jung Hun
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (06) : 2371 - 2376
  • [42] Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: A phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group
    Gridelli, C
    Gallo, C
    Shepherd, FA
    Illiano, A
    Piantedosi, F
    Robbiati, SF
    Manzione, L
    Barbera, S
    Frontini, L
    Veltri, E
    Findlay, B
    Cigolari, S
    Myers, R
    Ianniello, GP
    Gebbia, V
    Gasparini, G
    Fava, S
    Hirsh, V
    Beziak, A
    Seymour, L
    Perrone, F
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (16) : 3025 - 3034
  • [43] A multicenter phase II study of gemcitabine, paclitaxel, and cisplatin in chemonaive advanced ovarian cancer
    Gupta, SK
    John, S
    Naik, R
    Arora, R
    Selvamani, B
    Fuloria, J
    Ganesh, N
    Awasthy, BS
    GYNECOLOGIC ONCOLOGY, 2005, 98 (01) : 134 - 140
  • [45] A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer
    In Gyu Hwang
    Joung-Soon Jang
    Sung Yong Oh
    Suee Lee
    Hyuk Chan Kwon
    Gyeong Won Lee
    Seil Go
    Myoung Hee Kang
    Young Joo Cha
    Jung Hun Kang
    Investigational New Drugs, 2012, 30 : 2371 - 2376
  • [46] Phase II trial of gemcitabine in combination with cisplatin in inoperable or advanced hepatocellular carcinoma
    Chia, Whay Kuang
    Ong, Simon
    Toh, Han Chong
    Hee, Siew Wan
    Choo, Su Pin
    Poon, Donald Y. H.
    Tay, Miah Hiang
    Tan, Chee Kiat
    Koo, Wen Hsin
    Foo, Kian Fong
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2008, 37 (07) : 554 - 558
  • [47] Randomized Phase III Study Comparing Paclitaxel/Cisplatin/Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer Without Prior Systemic Therapy: EORTC Intergroup Study 30987
    Bellmunt, Joaquim
    von der Maase, Hans
    Mead, Graham M.
    Skoneczna, Iwona
    De Santis, Maria
    Daugaard, Gedske
    Boehle, Andreas
    Chevreau, Christine
    Paz-Ares, Luis
    Laufman, Leslie R.
    Winquist, Eric
    Raghavan, Derek
    Marreaud, Sandrine
    Collette, Sandra
    Sylvester, Richard
    de Wit, Ronald
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (10) : 1107 - 1113
  • [48] Randomized phase III study of Gemcitabine/cisplatin versus mitomycin/ifosfamide/cisplatin in advanced non-small cell lung cancer (NSCLC)
    Scagliotti, G
    Crino, L
    Conte, PF
    Rinaldi, M
    De Marinis, F
    Gridelli, C
    ANNALS OF ONCOLOGY, 1998, 9 : 85 - 85
  • [49] A randomized phase II trial of durvalumab and tremelIMUmab with gemcitabine or gemcitabine and cisplatin compared to gemcitabine and cisplatin in treatment-naive patients with CHolangio- and gallbladdEr Carcinoma (IMMUCHEC)
    Vogel, A.
    Boeck, S.
    Waidmann, O.
    Bitzer, M.
    Wenzel, P.
    Belle, S.
    Springfeld, C.
    Schulze, K.
    Weinmann, A.
    Lindig, U.
    Trautwein, C.
    Dechow, T.
    Lammert, F.
    Plentz, R.
    Koehne, C-H.
    Kunzmann, V.
    Maenz, M.
    Kirstein, M. M.
    Saborowski, A.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S563 - S563
  • [50] A randomized phase II trial of neoadjuvant chemotherapy for patients with resectable pancreatic cancer: Gemcitabine alone vs. gemcitabine combined with cisplatin.
    Palmer, DH
    Stocken, DD
    Buckels, JAC
    Hewitt, H
    Markham, CE
    Mirza, D
    Johnson, PJ
    Hassan, AB
    Bramhall, SR
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 367S - 367S